NCT07540559
The Effect of Coffee Consumption on Balance
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 8 words Show 5 more changesShow less
- Completed without a posted recruiting period
- Primary completion date changed from estimate of May 1, 2027 to Aug 1, 2026
- Study sites: 0 to 1
- Start date changed from estimate of May 1, 2026 to Apr 3, 2026
- Secondary endpoints: details revised at 1 of 1 entry
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Single Leg Stance Test
Timeframe: Single assessment at baseline
Y Balance Test
Timeframe: Single assessment at baseline
Timed Up and Go (TUG) Test
Timeframe: Single assessment at baseline
Tandem Walking Test
Timeframe: Single assessment at baseline
Secondary (1)
Borg Rating of Perceived Exertion (RPE) Scale
Arms and interventions
Low coffee consumption group
0-100 mg caffeine consumers.
Moderate coffee consumption group
100-300 mg caffeine consumers.
High coffee consumption group
\>300 mg caffeine consumers.
Other: Daily coffee consumption (self-reported exposure)
Sites
1 site in 1 country
- Saglik Bilimleri UniversitesiIstanbul, Üsküdar, Turkey (Türkiye)